ES2663717T3 - Síntesis de derivados de 2-carboxamida-cicloamino-urea - Google Patents

Síntesis de derivados de 2-carboxamida-cicloamino-urea Download PDF

Info

Publication number
ES2663717T3
ES2663717T3 ES12706843.5T ES12706843T ES2663717T3 ES 2663717 T3 ES2663717 T3 ES 2663717T3 ES 12706843 T ES12706843 T ES 12706843T ES 2663717 T3 ES2663717 T3 ES 2663717T3
Authority
ES
Spain
Prior art keywords
formula
compound
cycloamine
carboxamide
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12706843.5T
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Erb
Isabelle Sylvie Gallou
Florian Karl KLEINBECK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2663717(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2663717T3 publication Critical patent/ES2663717T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES12706843.5T 2011-03-03 2012-03-01 Síntesis de derivados de 2-carboxamida-cicloamino-urea Active ES2663717T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03
US201161448774P 2011-03-03
PCT/EP2012/053559 WO2012117071A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Publications (1)

Publication Number Publication Date
ES2663717T3 true ES2663717T3 (es) 2018-04-16

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12706843.5T Active ES2663717T3 (es) 2011-03-03 2012-03-01 Síntesis de derivados de 2-carboxamida-cicloamino-urea

Country Status (33)

Country Link
US (3) US9650373B2 (enExample)
EP (1) EP2681192B1 (enExample)
JP (1) JP6022485B2 (enExample)
KR (1) KR101851421B1 (enExample)
CN (2) CN103402982B (enExample)
AR (2) AR088714A1 (enExample)
AU (1) AU2012222346B2 (enExample)
BR (1) BR112013021882A2 (enExample)
CA (1) CA2828509C (enExample)
CL (1) CL2013002521A1 (enExample)
CO (1) CO6751286A2 (enExample)
DK (1) DK2681192T3 (enExample)
EA (4) EA032802B1 (enExample)
EC (1) ECSP13012914A (enExample)
ES (1) ES2663717T3 (enExample)
GT (1) GT201300211A (enExample)
HU (1) HUE036319T2 (enExample)
IL (1) IL228023A (enExample)
MA (1) MA34982B1 (enExample)
MX (2) MX351740B (enExample)
MY (1) MY163214A (enExample)
NO (1) NO2681192T3 (enExample)
PE (1) PE20140917A1 (enExample)
PH (1) PH12013501796A1 (enExample)
PL (1) PL2681192T3 (enExample)
PT (1) PT2681192T (enExample)
SG (1) SG192793A1 (enExample)
SI (1) SI2681192T1 (enExample)
TN (1) TN2013000354A1 (enExample)
TW (2) TWI607994B (enExample)
UA (1) UA112539C2 (enExample)
WO (1) WO2012117071A1 (enExample)
ZA (1) ZA201306174B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
CN107108442A (zh) * 2014-11-14 2017-08-29 燿石治疗公司 用于制备α,ω‑二羧酸封端的二烷醚的方法和中间体
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
CA2384101A1 (en) 1999-09-10 2001-03-15 Merck & Co., Inc. Tyrosine kinase inhibitors
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
EP1983980A4 (en) * 2006-01-25 2010-05-05 Synta Pharmaceuticals Corp THIAZOL AND THIADIAZOL COMPOUNDS FOR USES IN RELATION TO INFLAMMATION AND IMMUNITY
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
WO2009080694A1 (en) 2007-12-20 2009-07-02 Novartis Ag Thiazole derivatives used as pi 3 kinase inhibitors
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
CN103402982B (zh) 2016-07-13
MA34982B1 (fr) 2014-03-01
EA201792068A2 (ru) 2018-01-31
KR20140009432A (ko) 2014-01-22
TW201247660A (en) 2012-12-01
MX2013010132A (es) 2013-10-30
UA112539C2 (uk) 2016-09-26
AR088714A1 (es) 2014-07-02
EP2681192B1 (en) 2017-12-27
PL2681192T3 (pl) 2018-06-29
ZA201306174B (en) 2014-05-28
CL2013002521A1 (es) 2014-02-14
MX347348B (es) 2017-04-17
PH12013501796A1 (en) 2022-10-26
EA201792068A3 (ru) 2018-05-31
JP2014511387A (ja) 2014-05-15
EP2681192A1 (en) 2014-01-08
WO2012117071A1 (en) 2012-09-07
DK2681192T3 (en) 2018-04-16
EA032802B1 (ru) 2019-07-31
BR112013021882A2 (pt) 2016-07-19
TWI597279B (zh) 2017-09-01
EA201691331A1 (ru) 2017-01-30
MX351740B (es) 2017-10-26
TW201722916A (zh) 2017-07-01
AR123584A2 (es) 2022-12-21
MY163214A (en) 2017-08-30
JP6022485B2 (ja) 2016-11-09
EA201391267A1 (ru) 2014-01-30
CN106083840A (zh) 2016-11-09
PT2681192T (pt) 2018-04-02
TWI607994B (zh) 2017-12-11
ECSP13012914A (es) 2013-11-29
US20170355677A1 (en) 2017-12-14
NZ614173A (en) 2015-04-24
PE20140917A1 (es) 2014-08-14
EA025381B1 (ru) 2016-12-30
GT201300211A (es) 2014-12-30
US10059670B2 (en) 2018-08-28
SI2681192T1 (en) 2018-04-30
US20170240509A1 (en) 2017-08-24
CO6751286A2 (es) 2013-09-16
KR101851421B1 (ko) 2018-04-23
CA2828509C (en) 2018-11-20
US9650373B2 (en) 2017-05-16
SG192793A1 (en) 2013-09-30
AU2012222346A1 (en) 2013-08-29
CA2828509A1 (en) 2012-09-07
TN2013000354A1 (en) 2015-01-20
EA201892052A1 (ru) 2019-02-28
IL228023A0 (en) 2013-09-30
US20130331579A1 (en) 2013-12-12
CN106083840B (zh) 2020-01-03
US9776966B2 (en) 2017-10-03
CN103402982A (zh) 2013-11-20
IL228023A (en) 2017-04-30
HUE036319T2 (hu) 2018-06-28
NO2681192T3 (enExample) 2018-05-26
AU2012222346B2 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
ES2663717T3 (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
ES2624795T3 (es) Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica
ES2521596T3 (es) Combinación del compuesto GlyT1 con antipsicóticos
AR066107A1 (es) Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen.
CO6280509A2 (es) Derivados de carboxamidas azabiciclicas su preparacion y su aplicacion en terapeutica
AR080314A1 (es) Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa
CU20140105A7 (es) Composición para el control de plagas que incluye un derivado de iminopiridina novedoso
AR066709A1 (es) Proceso para la produccion de pirazoles
CU23840B1 (es) Nuevos derivados de sulfonamida como antagonistas de la bradiquinina
BR112015029182A2 (pt) composto para uso em modulação da rota wnt, uso do composto, método, composição farmacêutica, forma anidra, uso de uma base livre anidra
DOP2010000227A (es) Derivados biciclicos de carboxamidas aza-biciclicas, su preparacion y su aplicacion terapeutica
CR20110135A (es) INHIBIDORES DE cMET
AR075332A1 (es) Dionas ciclicas como herbicidas
AR052568A1 (es) Derivados de pirazolo -pirimidina como antagonstas de mglur2
AR075498A1 (es) Metodos para la preparacion de arilamidas
CO6150181A2 (es) Compuesto 6-(bencilo sustituido con heterociclo)-4-oxoquinolina y su uso como inhibidor de integrasa vih
DOP2010000089A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas
AR080802A1 (es) Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemias por deficiencia de hierro
AR098270A1 (es) Poliéster terminado en epoxi
AR114493A2 (es) Procesos para la preparación de derivados de ciclopropilamida
CY1115635T1 (el) Παραγωγα 2-πυριδιν-2-υλο-πυραζολ-3(2η)-ονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
ES2655265T3 (es) Procedimiento de preparación de bifenilanilidas sustituidas
ES2641372T3 (es) Inhibidores de replicación viral, su proceso de preparación y sus usos terapéuticos
ES2584556T3 (es) Composiciones novedosas que contienen carbodiimida, un procedimiento para su preparación y su uso
AR082912A1 (es) Metodo para producir compuestos de piridazinona y un intermediario de sintesis